161 related articles for article (PubMed ID: 34923809)
21. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.
Oortwijn W; Husereau D; Abelson J; Barasa E; Bayani DD; Canuto Santos V; Culyer A; Facey K; Grainger D; Kieslich K; Ollendorf D; Pichon-Riviere A; Sandman L; Strammiello V; Teerawattananon Y
Value Health; 2022 Jun; 25(6):869-886. PubMed ID: 35667778
[TBL] [Abstract][Full Text] [Related]
22. International comparison of comparative effectiveness research in five jurisdictions: insights for the US.
Levy AR; Mitton C; Johnston KM; Harrigan B; Briggs AH
Pharmacoeconomics; 2010; 28(10):813-30. PubMed ID: 20831289
[TBL] [Abstract][Full Text] [Related]
23. Deliberative processes in decision making informed by health technology assessment in Latin America.
Alcaraz A; Pichon-Riviere A; García-Martí S; Alfie V; Augustovski F; Castro H
Int J Technol Assess Health Care; 2022 Dec; 38(1):e86. PubMed ID: 36524558
[TBL] [Abstract][Full Text] [Related]
24. HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe".
Schlander M
Int J Health Policy Manag; 2021 Mar; 10(3):158-161. PubMed ID: 32610783
[TBL] [Abstract][Full Text] [Related]
25. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
[TBL] [Abstract][Full Text] [Related]
26. The Use of Evidence-Informed Deliberative Processes for Health Insurance Benefit Package Revision in Iran.
Nouhi M; Baltussen R; Razavi SS; Bijlmakers L; Sahraian MA; Goudarzi Z; Farokhian P; Khedmati J; Jahangiri R; Olyaeemanesh A
Int J Health Policy Manag; 2022 Dec; 11(11):2719-2726. PubMed ID: 35247943
[TBL] [Abstract][Full Text] [Related]
27. Health technology assessment for sexual reproductive health and rights benefits package design in sub-Saharan Africa: A scoping review of evidence-informed deliberative processes.
Simangolwa WM; Mbonigaba J; Govender K
PLoS One; 2024; 19(6):e0306042. PubMed ID: 38935794
[TBL] [Abstract][Full Text] [Related]
28. Implicit factors influencing the HTA deliberative processes in 5 European countries: results from a mixed-methods research.
Monleón C; Martin-Späth H; Crespo C; Dussart C; Toumi M
Health Policy Open; 2023 Dec; 5():100109. PubMed ID: 38073709
[TBL] [Abstract][Full Text] [Related]
29. Fair Processes for Priority Setting: Putting Theory into Practice Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".
Jansen MP; Helderman JK; Boer B; Baltussen R
Int J Health Policy Manag; 2017 Jan; 6(1):43-47. PubMed ID: 28005541
[TBL] [Abstract][Full Text] [Related]
30. Principles for deliberative processes in health technology assessment.
Bond K; Stiffell R; Ollendorf DA
Int J Technol Assess Health Care; 2020 Aug; ():1-8. PubMed ID: 32746954
[TBL] [Abstract][Full Text] [Related]
31. Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland.
Allen N; Walker SR; Liberti L; Salek S
Value Health; 2017 Mar; 20(3):320-328. PubMed ID: 28292476
[TBL] [Abstract][Full Text] [Related]
32. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
[TBL] [Abstract][Full Text] [Related]
33. Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study.
Jenei K; Raymakers AJN; Bayle A; Berger-Thürmel K; Cherla A; Honda K; Jackson CCGA; Karikios D; Trapani D; Berry S; Gyawali B
Lancet Oncol; 2023 Jun; 24(6):624-635. PubMed ID: 37269843
[TBL] [Abstract][Full Text] [Related]
34. Introducing patient perspective in health technology assessment at the local level.
Gagnon MP; Lepage-Savary D; Gagnon J; St-Pierre M; Simard C; Rhainds M; Lemieux R; Gauvin FP; Desmartis M; Légaré F
BMC Health Serv Res; 2009 Mar; 9():54. PubMed ID: 19327160
[TBL] [Abstract][Full Text] [Related]
35. An International Review of Health Technology Assessment Approaches to Prescription Drugs and Their Ethical Principles.
Rand LZ; Kesselheim AS
J Law Med Ethics; 2020 Sep; 48(3):583-594. PubMed ID: 33021189
[TBL] [Abstract][Full Text] [Related]
36. Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders' capacity, needs, policy areas of demand and perspectives in Nigeria.
Uzochukwu BSC; Okeke C; O'Brien N; Ruiz F; Sombie I; Hollingworth S
Global Health; 2020 Jul; 16(1):58. PubMed ID: 32641066
[TBL] [Abstract][Full Text] [Related]
37. Institutionalisation Is a Vital Element for Fairness of Priority Setting in the Package Design if the Target is Universal Health Coverage Comment on "Evidence-Informed Deliberative Processes for Health Benefits Package Design - Part II: A Practical Guide".
Sajadi HS; Jama M; Majdzadeh R
Int J Health Policy Manag; 2023; 12():7544. PubMed ID: 37579458
[TBL] [Abstract][Full Text] [Related]
38. PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FOR ACTION.
Abelson J; Wagner F; DeJean D; Boesveld S; Gauvin FP; Bean S; Axler R; Petersen S; Baidoobonso S; Pron G; Giacomini M; Lavis J
Int J Technol Assess Health Care; 2016 Jan; 32(4):256-264. PubMed ID: 27670693
[TBL] [Abstract][Full Text] [Related]
39. Systematic literature review on the implicit factors influencing the HTA deliberative process in Europe.
Monleón C; Späth HM; Crespo C; Dussart C; Toumi M
J Mark Access Health Policy; 2022; 10(1):2094047. PubMed ID: 35811835
[TBL] [Abstract][Full Text] [Related]
40. The use of nonrandomized evidence to estimate treatment effects in health technology assessment.
Kent S; Salcher-Konrad M; Boccia S; Bouvy JC; Waure C; Espin J; Facey K; Nguyen M; Rejon-Parrilla JC; Jonsson P
J Comp Eff Res; 2021 Oct; 10(14):1035-1043. PubMed ID: 34279114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
